Helix BioPharma Corp

Industry

  • Biotechnology
    • Drug Discovery Technologies
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Drug Delivery

Other Names/Subsidiaries

  • Helix Polska
  • Helix BioPharma Corp
  • Helix Immuno-Oncology Spolka Akcyjna
  • Helix Polska
  • Laevoroc Chemotherapy
  • Laevoroc Immunology
  • 4 cell therapies
See more in Biomedtracker

Latest on Helix BioPharma Corp

In Vivo

Execs On The Move, April 2017

 
• By Regina Paleski

Company Changes ADAMS , Derek, PhD To: bluebird bio Inc. , Chief Technology & Mfg. Officer (March) From: Evelo Biosciences, SVP, CMC Phone: 339-499-9300 ARBET-ENGELS , Christophe, MD, PhD To:

In Vivo

Execs On The Move, February 2016

 
• By Regina Paleski

New At The Helm Company Changes ALLEN , Lee F., MD, PhD To: Argos Therapeutics Inc. , CMO (January) From: Spectrum Pharmaceuticals Inc., CMO Phone: 919-287-6300 ANSARI , Nick To: EnteroMedi

In Vivo

Execs On The Move, November 2015

 
• By Regina Paleski

New At The Helm Company Changes ALMEIDA , Joe To: Baxter International Inc. , Chmn. & CEO (Jan. 2016) From: Covidien PLC, Pres. & CEO Phone: 847-948-2000 AVILA , Manny To: IlluminOss Medica

Scrip

Takeda strengthens cancer focus with Mersana ADC deal

 
• By Gemma Collier

Takeda is ramping up its presence in oncology, having signed a deal with antibody-drug conjugate (ADC) specialist Mersana Therapeutics via subsidiary Millennium Pharmaceuticals. In an interview with